TrialBritish journal of haematology2020

Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.

Régis Peffault de Latour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.